International Clinical Psychopharmacology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.0 | Q2 | 62.5% | 0.781 | Q2 | 76.5% |
| 2024 | 2.5 | Q2 | 55.2% | 0.642 | Q2 | 70.7% |
| 2023 | 2.1 | Q3 | 49.2% | 0.621 | Q2 | 72.1% |
| 2022 | 2.6 | Q3 | 51.1% | 0.672 | Q2 | 75.6% |
| 2021 | 2.0 | Q4 | 39.1% | 0.521 | Q2 | 68.4% |
| 2020 | — | — | 0.559 | Q2 | 69.8% | |
| 2019 | — | — | 0.799 | Q2 | 80.4% | |
| 2018 | — | — | 0.834 | Q2 | 79.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1473-5857
ISSN
0268-1315
country
UScoverage
1986-2026